CODEX DNA INC
CODEX DNA INC logo
DNAY

CODEX DNA INC (DNAY)

$1.381.47%

Market is closed
– opens on 8 PM, 05 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$1.3501
Day's Range
$1.39
$1.35
52-Week Range
$11.32
1 month return9.8%
3 month return21.59%
1 year return78.47%
5 year return92.04%

Company Information

Codex DNA is a synthetic biology company focused on enabling researchers to rapidly, accurately and reproducibly build or “write” high-quality synthetic DNA and mRNA that is ready to use in many downstream synthetic biology enabled markets. Codex DNA’s synthetic biology solution addresses the bottlenecks across the multi-step process of building DNA and mRNA, as well as the significant limitations of existing solutions that prevent the rapid building of virtually error-free DNA and mRNA at a useable scale. A key part of Codex DNA’s solution is the BioXp™ system, an end-to-end automated workstation that fits on the benchtop and is broadly accessible due to its ease-of-use and hands-free automation. Codex DNA believes the BioXp™ system can democratize synthetic biology by simplifying the process of building DNA and mRNA, thereby accelerating the discovery, development, and production of novel high-value products, including antibody-based biologics, mRNA-based vaccines and therapeutics and precision medicines.
OrganizationCODEX DNA INC
Employees212
CEODr. Todd R. Nelson MBA, Ph.D.
IndustryHealthcare

Analyst Recommendation

based on 3 analysts ratings

Buy
100%
Buy
0%
Hold
0%
Sell

Based on 3 Wall street analysts offering stock ratings for CODEX DNA INC(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 371.01%

Current

$1.38

Target

$6.5

Recommendation Trend

Based on 3 analyst

Current1M Ago3M Ago
Buy
3
8
8
Hold
0
1
1
Sell
0
0
0
Consensus
BUY
BUY
BUY

Highlights

Market Capitalization
40.1M
Book Value
$1.81
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-1.84
Wall Street Target Price
6.5

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)
0.79
Enterprise Value
13.5M
Enterprise Value/Revenue
0.64
Enterprise Value/Ebitda
-0.28

Technicals

50 Day MA
1.68
200 Day MA
3.52

Institutional Holdings

Northpond Ventures, LLC

33.35%

Franklin Resources Inc

8.06%

Millennium Management LLC

1.47%

Vanguard Group Inc

1.39%

Penbrook Management LLC

0.91%

RTW INVESTMENTS, LLC

0.34%

Discover more

Frequently Asked Questions

What is CODEX DNA INC share price today?

Can Indians buy CODEX DNA INC shares?

How can I buy CODEX DNA INC shares from India?

Can Fractional shares of CODEX DNA INC be purchased?

What are the documents required to start investing in CODEX DNA INC stocks?

What are today’s High and Low prices of CODEX DNA INC?

What are today’s traded volumes of CODEX DNA INC?

What is today’s market capitalisation of CODEX DNA INC?

What is the 52 Week High and Low Range of CODEX DNA INC?

How much percentage CODEX DNA INC is down from its 52 Week High?

How much percentage CODEX DNA INC is up from its 52 Week low?

What are the historical returns of CODEX DNA INC?

Who is the Chief Executive Officer (CEO) of CODEX DNA INC?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*